Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
Phase I investigation of the cMet inhibitor MK-8033 is ongoing
Smiles: CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@]12C
10-13H2/t17-/m1/s1/i1D2
Esculentoside H (EsH) has anti-tumor activity
InChi: InChI=1S/C44H42F3N7O12/c1-62-33-22-25(8-10-28(33)51-43-49-23-27(44(45
Lercanidipine-d3 hydrochloride Size:Contact [email protected] for quotation Phase I investigation of theLercanidipine d3 hydrochloride is the deuterium labeled Lercanidipine. Lercanidipine is a lipophilic third generation dihydropyridine calcium channel blocker (DHP CCB). Lercanidipine has long lasting antihypertensive action and reno protective effect. Product information CAS Number: 1189954 18 4 Molecular Weight: 651. 21 Formula: C36H42ClN3O6 Chemical Name: 3 {1 [(3,3 diphenylpropyl)((H)methyl)amino] 2 methylpropan 2 yl} 5 methyl 2,6 dimethyl 4 (3
US$ 87.00
US$ 45.00
US$ 109.00
US$ 76.00